|
Journal of Lipid Research, Vol 32, 1465-1476, Copyright © 1991 by Lipid Research, Inc.
Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III
A von Eckardstein, M Walter, H Holz, A Benninghoven and G Assmann
Institut fur Klinische Chemie und Laboratoriumsmedizin, Westfalische Wilhelms-Universitat Munster, Germany.
ApoA-I and apoC-II are eluted in two isoforms and apoC-III2 is eluted in
three isoforms by reversed phase high performance liquid chromatography
(HPLC). The structural basis of these nongenetic heterogeneities was
unravelled using HPLC of proteolytic peptides and time-of-flight secondary
ion mass spectrometry (TOF-SIMS). In apoA-I, the chromatographic
microheterogeneity was caused by the formation of methionine sulfoxides
(MetSO). However, only residues Met112 and Met148 were found oxidized,
whereas Met86 was unaffected and also resistant towards artificial
oxidation. To assess whether and to what extent amino acid substitutions in
apoA-I might affect methionine sulfoxidation, the tryptic peptides of 13
different mutant apoA-I proteins from 24 heterozygous apoA-I variant
carriers were analyzed by HPLC. In normal apoA-I, the ratios
MetSO112/Met112 and MetSO148/Met148 were highly variable. By contrast, the
relative ratio of oxidation of methionine residues 112 and 148 was
constant. The amino acid changes Lys107----Met, Lys107----O, Glu139----Gly,
Glu147----Val, and Pro165---- Arg resulted in the preferential oxidation of
Met112, and Asp103----Asn resulted in a preferential oxidation of Met148;
whereas Pro3----Arg, Pro3----His, Pro4----Arg, Asp89----Glu, Ala158----Asp,
Glu198----Lys, and Asp213----Gly had no impact. ApoC-II and apoC-III
isoforms differed by the oxidation of the two methionine residues in these
proteins. Whereas in apoC-II both methionine residues were oxidized in
parallel, in apoC-III the two methionine residues differed in their
susceptibility towards oxidation. We conclude that the formation of MetSO
depends on the molecular microenvironment within a protein.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. W. C. Brock, A. J. Jenkins, T. J. Lyons, R. L. Klein, E. Yim, M. Lopes-Virella, R. E. Carter, (DCCT/EDIC) Research Group, S. R. Thorpe, and J. W. Baynes
Increased methionine sulfoxide content of apoA-I in type 1 diabetes
J. Lipid Res.,
April 1, 2008;
49(4):
847 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sako, E. Uchida, Y. Kagawa, K. Hirayama, T. Nakade, and H. Taniyama
Immunohistochemical Detection of Apolipoprotein A-I and B-100 in Canine Atherosclerotic Lesions
Veterinary Pathology,
May 1, 2003;
40(3):
328 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pankhurst, X. L. Wang, D. E. Wilcken, G. Baernthaler, U. Panzenbock, M. Raftery, and R. Stocker
Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein
J. Lipid Res.,
February 1, 2003;
44(2):
349 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Bondarenko, S. L. Cockrill, L. K. Watkins, I. D. Cruzado, and R. D. Macfarlane
Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein
J. Lipid Res.,
March 1, 1999;
40(3):
543 - 555.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Mashima, Y. Yamamoto, and S. Yoshimura
Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma
J. Lipid Res.,
June 1, 1998;
39(6):
1133 - 1140.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. von Eckardstein, A. Chirazi, S. Schuler-Luttmann, M. Walter, J. J. P. Kastelein, J. Geisel, J. T. Real, R. Miccoli, G. Noseda, G. Hobbel, et al.
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
J. Lipid Res.,
May 1, 1998;
39(5):
987 - 998.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Garner, P. K. Witting, A. R. Waldeck, J. K. Christison, M. Raftery, and R. Stocker
Oxidation of High Density Lipoproteins. I. FORMATION OF METHIONINE SULFOXIDE IN APOLIPOPROTEINS AI AND AII IS AN EARLY EVENT THAT ACCOMPANIES LIPID PEROXIDATION AND CAN BE ENHANCED BY alpha -TOCOPHEROL
J. Biol. Chem.,
March 13, 1998;
273(11):
6080 - 6087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Garner, A. R. Waldeck, P. K. Witting, K.-A. Rye, and R. Stocker
Oxidation of High Density Lipoproteins. II. EVIDENCE FOR DIRECT REDUCTION OF LIPID HYDROPEROXIDES BY METHIONINE RESIDUES OF APOLIPOPROTEINS AI AND AII
J. Biol. Chem.,
March 13, 1998;
273(11):
6088 - 6095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang, Y. Zhu, C. Langer, M. Raabe, S. Wu, B. Wiesenhutter, U. Seedorf, N. Maeda, G. Assmann, and A. von Eckardstein
Effects of Genotype and Diet on Cholesterol Efflux into Plasma and Lipoproteins of Normal, Apolipoprotein A-I-, and Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol,
October 1, 1997;
17(10):
2010 - 2019.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. L. Levine, L. Mosoni, B. S. Berlett, and E. R. Stadtman
Methionine residues as endogenous antioxidants in proteins
PNAS,
December 24, 1996;
93(26):
15036 - 15040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang, A. von Eckardstein, S. Wu, C. Langer, and G. Assmann
Generation of Pre-ß1-HDL and Conversion Into {alpha}-HDL : Evidence for Disturbed HDL Conversion in Tangier Disease
Arterioscler Thromb Vasc Biol,
October 1, 1995;
15(10):
1746 - 1754.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
U. Panzenbock, L. Kritharides, M. Raftery, K.-A. Rye, and R. Stocker
Oxidation of Methionine Residues to Methionine Sulfoxides Does Not Decrease Potential Antiatherogenic Properties of Apolipoprotein A-I
J. Biol. Chem.,
June 23, 2000;
275(26):
19536 - 19544.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|